Case Study: Noble Biomaterials achieves one version of the truth with QAD Adaptive ERP (QAD)

Noble Biomaterials Turns to QAD for Improved Data Accuracy

Noble Biomaterials is an FDA- and EPA‑registered manufacturer of silver‑based antimicrobial materials used in medical and defense settings. Rapid growth and a patchwork of third‑party systems, spreadsheets and manual processes left stakeholders without a single, trusted source of data—creating inconsistencies in manufacturing, sales forecasting and operations that hampered decision making and scalability.

Noble implemented QAD Adaptive ERP in the cloud—including Adaptive UX, QAD Production Execution, Automation Solutions and a rolling sales‑forecast app—to standardize processes and capture real‑time shop‑floor and business data. The result was a unified system of record with better KPIs and analytics, elimination of much manual tracking, faster invoicing and reduced overtime, and an 80% cut in third‑party customizations, enabling more reliable operations and support for continued growth.

Noble Biomaterials

Tom Bross

Chief Financial Officer